IP Library Granted Patent US 11,432,573
Granted Patent B2
US 11,432,573 · App. 16/751,379 · Granted Sep 6, 2022

Food and beverage sweeteners

Inventor: Franco Cavaleri (Surrey, CA)
A23L27/36A23L27/31A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,432,573
App. No.
16/751,379
Granted
Sep 6, 2022
Kind
B2
Abstract

Natural sweetener compositions are disclosed, which generally include various combinations of steviol glycosides extracted from a Stevia rebaudiana plant; Siraitia grosvenorii (Monk Fruit) plant extract (including mogrosides extracted from such plant species); and an amino acid component consisting of free glycine. The natural sweetener compositions may optionally further include gymnemic acid (such as an extract of a Gymnemic sylvestre herb that includes 25%-75% gymnemic acid). The natural sweetener compositions may consist essentially of those two, three, or four components—or may be included in beverages, beverage powders, and foods.

Claims (14)

1. A composition for adding a sweet flavor to foods and beverages, which consists essentially of:

(a) mogrosides extracted from a Siraitia grosvenorii plant; and

(b) an amino acid component consisting of free glycine.

2. The composition of claim 1 , which further includes gymnemic acid.

3. The composition of claim 1 , wherein the mogrosides is mogroside V.

4. The composition of claim 1 , wherein the composition is effective to induce insulinogenic activity within pancreatic beta cells.

5. A composition for adding a sweet flavor to foods and beverages, which consists essentially of:

(a) mogrosides extracted from a Siraitia grosvenorii plant;

(b) an amino acid component consisting of free glycine: and

(c) steviol glycosides extracted from a Stevia rebaudiana plant.

6. The composition of claim 5 , which further comprises gymnemic acid.

7. The composition of claim 1 , wherein the gymnemic acid consists of an extract of a Gymnemic sylvestre herb, wherein said extract comprises 25%-75% gymnemic acid.

8. The composition of claim 5 , wherein the mogrosides is mogroside V.

9. The composition of claim 5 , wherein the composition is effective to induce insulinogenic activity within pancreatic beta cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2023
From: CAVALERI, FRANCO
To: CAVALERI HEALTH, INC.
Reel/Frame 064017/0018 →
Continuity (3)
Continuation In Part 16483090
Provisional Application 62537876 · Jul 27, 2017
Related Publication 20200154748A1 · May 21, 2020